It is a well-established fact that tumors up-regulate glucose consumption to meet increasing demands for rapidly available energy by switching to purely glycolytic mode of glucose metabolism. What is often neglected is that cytotoxic cells of the immune system also have increased energy demands and also switch to pure glycolysis when they are in an activated state. Moreover, while cancer cells can revert back to aerobic metabolism, rapidly proliferating cytotoxic lymphocytes are incapable of performing their function when adequate resources are lacking. Consequently, in the tumor microenvironment there must exist competition for the common resources between cancer cells and the cells of the immune system, which may drive a lot of the tumorimmune dynamics. Proposed here is a model of tumor-immune-glucose interactions, formulated as a predator-prey-common resource type system, which allows to investigate possible dynamical behaviors that may arise as a result of competition for glucose, including tumor elimination, tumor dormancy and unrestrained tumor growth.
Introduction
Immunoediting is the process whereby the immune system can alter, or 'edit', the progression of tumor growth. It has been proposed that the process of immunoediting consists of three distinct phases: elimination phase, when the cytotoxic cells of the immune system reduce tumor size, equilibrium, when tumor size is maintained at a constant level, and escape, when the tumor circumvents the immune response, as tumor cells develop resistance and start growing again (1) (2) (3) . The process of tumor escape is believed to be driven by mutations, and specifically, by the eventual appearance and subsequent selection for non-immunogenic tumor clones (2) . We propose that circumvention of the immune system and subsequent tumor escape is not necessarily a result of increased genomic instability but can be explained solely by competition for common resources between cancer and immune cells in the tumor microenvironment.
It is a well-established fact that tumor cells can significantly up-regulate glucose consumption to meet the high energetic demands for cell survival and proliferation. Intriguingly, they frequently switch to fast but less efficient purely glycolytic mode of glucose metabolism even in the areas of ample oxygen supply, which yields 2 molecules of ATP compared to approximately 30 ATP that would have been obtained as a result of oxidative phosphorylation (4) (5) (6) . Advantages of up-regulated glycolysis include not only significantly increased speed of access to the generated ATP but also the ability to divert glucose intermediates for new cell manufacturing (7; 8) . A switch to pure glycolysis as a primary mode of glucose metabolism is often accompanied by up to 30-fold increase in glucose uptake and over-expression of glucose transporters, such as GLUT-1 and SGLT-1 (9) . Similarly, actively proliferating cytotoxic lymphocytes also switch to purely glycolytic mode of glucose metabolism, which is accompanied by a similar up-regulation of the expression of glucose transporters, such as GLUT-1 (10) . Moreover, failure to increase glucose uptake during lymphocyte activation prevents cell growth and limits cell functionality, as cells deprived of adequate glucose supply cannot produce cytokines such as IFN-γ, which are required for effector function (11; 12) . Therefore, it is not unreasonable to assume that in the tumor microenvironment there can exist competition for glucose between tumor and immune cells, and the outcome of this interaction would be determined by whichever cell type is the first to acquire access to glucose. This hypothesis relies specifically on the fact that T cells proliferate not only in the periphery but also in the tumor microenvironment (Thompson et al. 2010 ).
These considerations allow to conceive of the following theoretical set-up: as the primary tumor grows, the cells inside it switch to glycolysis due to oxygen deprivation, establishing a glycolytic core, while the cells on the outside of the tumor may still continue using more energy efficient aerobic metabolism. Assuming sufficient tumor immunogenicity and functional immune response, actively proliferating immune cells that are attracted to the tumor cite are expected to be able to succeed in competition for glucose at this stage of the tumor-immune interaction, since, unlike aerobic cancer cells that they are coming in contact with, immune cells are using purely glycolytic mode of metabolism, which, as was pointed out above, is accompanied by significant upregulation of nutrient transporters. As a result of successful tumor 'contraction' by the immune cells, glycolytic core of the tumor could become exposed, and these glycolytic tumor cells can now actively compete with the immune cells for the available glucose. Should the immune cells not be able to succeed (if, for instance, selection for extremely up-4 regulated nutrient transporters was more severe in the oxygen-deprived tumor core than it was for the immune cells in their environment), then they will not be able to undergo clonal expansion, thus allowing the tumor to circumvent the immune system and continue growing. A schematic representation of the proposed scenario is given in Figure 1 . Figure 1 . Proposed scenario of metabolism-driven tumor escape. In the tumor microenvironment, glucose is taken up by cytotoxic lymphocytes that use glycolysis as a primary mode of metabolism, causing the tumor to contract and exposing its glycolytic core. The glycolytic tumor cells have up-regulated nutrients transporters, thus posing competition to immune cells for resources. Lymphocytes cannot proliferate unless their nutrient demands are met, which can allow tumor cells to circumvent immune response, leading to tumor escape.
We introduce a mathematical model in order to investigate whether such a behavior can indeed be realized using the most basic set of assumptions about tumorimmune-glucose interactions, as well as to study any other possible regimes that may arise in such a system. The proposed model is a 4-dimensional system of ordinary differential equations of the form predator-prey-common resource, where the cytotoxic lymphocytes are the predator, cancer cells are the prey, and glucose is the common resource. We hypothesize that depending on glucose availability we'll be able to observe the escape phase of immunoediting, which will be driven purely by competition for resources in the tumor microenvironment.
Model Description
Proposed here is a conceptual mathematical model aimed to describe the dynamical interactions between a heterogeneous population of tumor cells (prey) and cytotoxic immune cells (predator), competing for glucose in the tumor microenvironment (the common resource). The assumptions that were used in model formulation can be summarized as follows:
1. Tumor population consists of aerobic and glycolytic cells.
2. Glycolytic tumor cells grow faster but also deplete common resources faster (they have higher nutrient uptake rates). Taking all of these assumptions into account, we end up with the following system of ordinary differential equations:
dG dt
cell expansion stimulated by debris from previously killed tumor cells and modulated by glucose (1) Description of the parameters and sample values are given in Table 1 .
Results
The goal of the numerical computations conducted for this model is to investigate whether we can observe the theoretically predicted cycle of metabolism-modulated immune escape given the simplest set of assumptions outlined in Figure 1 (death rate of cytotoxic lymphocytes) on system dynamics because we believe that these parameters can, at least in theory, be manipulated in an experimental setting via various therapeutic interventions, such as chemo-, radiation and immunotherapy.
Aerobic and glycolytic tumor cells can cooperate to defeat the immune system
In the first set of simulations, we varied parameter i 0 and were indeed able to observe the theoretically predicted cyclical dynamics. Other parameters were held constant at b
. Parameter values were chosen based on the values provided in the validated mathematical models proposed by de Pillis et al. (14; 15) ; in other cases, parameter values were estimated based on theoretical considerations. It is important to emphasize that the primary purpose of the proposed model is to validate theoretical predictions, identify qualitative regimes that are possible within the described framework and to propose further research directions rather than to match predictions to specific pre-existing data.
As we progressively increased parameter i In such a scenario, the dynamics can be interpreted as cooperation between aerobic and glycolytic tumor cells against cytotoxic lymphocytes: glycolytic cells take up the resources, allowing the tumor to circumvent the immune system and for the more successful of the remaining tumor cells to grow (noticeably, these could be either aerobic or glycolytic cancer cells; however, the circumvention of the immune system is in this case modulated by glycolytic cancer cells).
The dynamics observed under these parameter values corresponds to the circular dynamics predicted in Figure 1 .
Increased immune stimulation can be sufficient to control tumor size but not to eliminate it
Next, we evaluated whether further increases in overall immune stimulation could lead to permanent tumor elimination; a positive answer would suggest that tumor growth could in some cases be controlled through immunotherapy alone. We observed that increasing the value of i 0 by five orders of magnitude did not lead to tumor elimination; it allowed destabilizing the tumor, yielding oscillatory regimes of a much smaller magnitude than in the previous set of simulations, but complete elimination was not observed (see Figure 4) . We then hypothesized that even with strong supplementary immune stimulation, tumor elimination can be achieved only if the parameter of tumor elimination e j is large enough (out of parameters that we are choosing to focus on in this paper as the ones that can be manipulated in a clinical setting). For this set of simulations, we fixed i 0 = 2.1e -4 and then progressively increased parameter e j (see Figure 5 ). We observed that progressively increasing the values of parameter m I lead to eventual rapid tumor escape, preceded by progressively increasing oscillatory regimes of small amplitude (see Figure 6 ). These results suggest that not only should effects of cytotoxic therapies on the immune cells be taken into account but also that immunemodulated tumor control can be disrupted if the patient is exposed to anything that could severely increase mortality of cytotoxic lymphocytes. 
Discussion
It is conventionally believed that the process of tumor escape from the immune system is driven by the eventual mutation induced appearance of non-immunogenic cell clones, which allow the cancer to progress unrecognized by the immune system. We propose that genomic instability of tumor cells is not imperative for immune escape, which can be mediated solely by competition for resources, and specifically glucose, between tumor and immune cells in the tumor microenvironment.
Actively proliferating cells, whether it be tumor or immune cells, up-regulate glycolysis as a primary mode of glucose metabolism, both due to its speed compared to more efficient but slower oxidative phosphorylation, and due to its ability to provide showed that such cyclical dynamics could in fact occur several times before the tumor either shrinks or escapes.
Next, we wanted to investigate whether the tumor can be eliminated through increased stimulation of the immune system alone, i.e., whether one could expect to cure the disease solely via extensive immune stimulation, such as through immunotherapy.
We observed that increasing immune stimulation by five orders of magnitude still did not yield complete tumor elimination. Only sufficiently increased killing of the tumor cells by the immune system was shown to lead to complete tumor elimination (see Figure 5 ).
These results suggest that immunotherapy could be an effective complementary therapy but it should not normally be expected to cure the cancer.
Finally, we evaluated the impact of high death rates of immune cells on overall tumor dynamics, since this parameter can be influenced both acutely as a side effect of cytotoxic therapies (18) (19) (20) (21) and chronically via environmental factors, such as low-dose radiation (unpublished data obtained in our lab); some studies also suggest that lymphocyte count recovery after anti-cancer treatment with cytotoxic drugs can serve as a predictor of superior survival in AML and ALL patients (22) (23) (24) . As expected, we observed that progressively increasing parameter of immune cell mortality lead to eventual tumor escape, preceded by progressively increasing oscillatory regimes of small amplitude (see Figure 6 ), suggesting that immune cell mortality could be another dimension along which predicted therapy efficacy should be evaluated. 
